OSTEOAMP - Differentiated Allograft

In vitro studies* show that OSTEOAMP retains up to 23 growth factors, including those present at each phase of the natural bone healing process.¹

^{*In vitro performance may not be predictive of performance in humans.}

The OSTEOAMP Difference

• Peer-reviewed publications report that OSTEOAMP is a viable alternative to Infuse^®, based on fusion rates and time to fusion in lumbar spine fusion.²
• OSTEOAMP is a differentiated and uniquely processed allograft.
• Our proprietary method of processing bone and bone marrow makes OSTEOAMP different from demineralized bone matrix (DBM) products that strip away bone marrow during processing, which reduces their potential for initiating osteoinduction and angiogenesis.

Economics

• OSTEOAMP was shown to be significantly less expensive per level than Infuse in a published study where 321 patients were evaluated in a TLIF/LLIF approach.²

Safety

• Donor bone is sourced from AATB-certified and FDA-registered tissue banks in the United States.
• All tissues are screened for the standard panel of infectious viruses.
• Manufacturing and sterilization processes have been validated to inactivate HIV-1, bovine herpes virus (BHV), bovine viral diarrhea virus (BVDV), hepatitis A virus (HAV) and porcine parvovirus (PPV).